← Leaderboards
Charles Kane
Starks Associates, Inc.
$1,866,861
Attributed
$1,866,861
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $945K · FY2009–17$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,866,861 · 2
By mechanism
N02$1,811,124 · 2
N01$55,737 · 1
Top collaborators
No co-investigators on record.
Most similar at Starks Associates, Inc.
Same institution · by research overlap
- David Starks$3,757,161
- Jack J Parsons$2,533,482
- John Givens$6,872,993
- Mark Middleton$5,058,723
- Jaroslav Novotny$410,982
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingModificationStagingPharmacodynamicsPropertyLeadDrug DevelopmentAnalogProgramsChemistryEvaluationRecommendationContractsBiologicalSmall MoleculeContractorArtsMethodologyChemical SynthesisLiteratureLibrariesFallsMalignant NeoplasmsCost
Grant awards (6)
OTHER FUNCTIONS THIS MODIFICATION PROVIDES FUNDING FOR WA'S 2, 3, AND 4; AND REV$28,900
N02 · FY2017 · CA · contact PI
OTHER FUNCTIONS THIS MODIFICATION PROVIDES FUNDING FOR WA'S 2, 3, AND 4; AND REV$55,737
N01 · FY2013 · CA · contact PI
OTHER FUNCTIONS THIS MODIFICATION PROVIDES FUNDING FOR WA'S 2, 3, AND 4; AND REV$416,596
N02 · FY2012 · CA · contact PI
Synthesis of Non-GMP Small Molecules$839,000
N02 · FY2010 · CA · contact PI
Synthesis of Non-GMP Small Molecules$106,000
N02 · FY2010 · CA · contact PI
Synthesis of Non-GMP Small Molecules$420,628
N02 · FY2009 · CA · contact PI